Buy-and-build confectionary and snacks group Zetar has churned out sweet results for the year to April and an acquisition since the year-end provides investors with even more to chew over.
Already becoming established as a leading niche producer of white-label chocolate products for UK supermarkets through its Kinnerton division, Zetar is in an excellent position to capitalise on the ever-increasing consumer interest in ‘healthier’ eating.
Last year the group expanded the confectionary division’s premium end with the acquisition of Salamander, a producer of fruit and nuts ‘enrobed’ in such coverings as Fair Trade chocolate or yoghurt. At its natural snacks division, Zetar also added organic dried fruit importer Humdinger to its existing fruit and nut business. Both arrivals have extended their product ranges and developed new products and will be beneficiaries of some of the £3m investment this year.
The post year-end acquisition of Britannia opened the door to the fast-growing, health-driven baked snacks and biscuits sector. Zetar’s chief executive Ian Blackburn says trading at loss-making Britannia should be much improved by Zetar’s ability to increase sales, but he admits it will ‘hold earnings back this year’.
Although Britannia will dominate in terms of management time this year, Blackburn has considerably strengthened the board to help push through the many plans to boost sales and increase synergies between divisions.
A barnstorming start has been made in the new year, with sales for the first 11 weeks of £12.4m versus the £7.1m last time. This has led independent broker Altium to upgrade 2008 forecasts to £7.2m pre-tax profit and 41.8p of earnings. Recommended by GCI at 335p in February last year, the shares have run out of steam a little of late but, considering the likely organic and acquisitive growth, we feel there is more to come. Add.
Market cap: £61.22m
PE Forecast: 13.6
Share price: 570p
£7,277 That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Diagnostic specialist Axis-Shield is seeking acquisitions to distribute its Afinion multi-illness tester after turning £4.3m losses into £11m profits.
For market research and consulting counter Cello, the music pretty much stopped in the first half of a demanding 2009. But having cut costs and noted recent trading improvements, the AIM-quoted company is making more positive noises about 2010.
Debt management and finance specialist Fairpoint Group plans new products and acquisitions after lifting annual pre-tax profits 420% to £5.7m.